17.03 AE 6.7, p <0.05) were significantly lower in the TAVI group. Incidence of LV dysfunction was similar in both groups (TAVI 8 vs SAVR 6, p¼0.77) but there was an increase incidence of mild to moderate aortic regurgitation in the TAVI group (TAVI 22 vs SAVR 9, p <0.05). Conclusion: Our initial results suggest excellent early haemodynamic performance of Edwards Sapien TAVI valve compared to the commonly used surgical bio prosthetic valves.
Introduction: Aortic Regurgitation (AR) post Transcatheter Aortic Valve Replacement (TAVR) was correlated with poor outcome. Heterogeneity in the clinical and procedural parameters associated with the post-TAVR of AR still exists. Methods: All patients undergoing TAVR (n¼407) had a post-procedural echocardiography and were grouped according to their AR degree into two groups (none/mild (n¼345) and AR>Mild (n¼62)). A comparison of the baseline, procedural characteristics and outcome metrics was performed. A multivariable logistic regression analysis was used to explore the variables associated with AR>mild. Results: Post procedural AR incidence was 79.11% in this cohort (322/407) with most patients having mild AR (63.8%; n¼260). After examining clinical and procedural parameters, only the left-ventricular outflow diameter (LVOT) was independently associated with AR>mid (figure-1).
Conclusion:
The reported etiologies for post-TAVR AR are multifactorial and include both patient and procedural characteristics. The association between LVOT diameter and post-TAVR AR suggested accurate valve size is imperative. Of the few modifiable parameters, appropriate valve sizing should be emphasized as it is the strongest predictor of post-TAVR AR development. 
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